BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30252965)

  • 1. T-Cell-Mimicking Nanoparticles Can Neutralize HIV Infectivity.
    Wei X; Zhang G; Ran D; Krishnan N; Fang RH; Gao W; Spector SA; Zhang L
    Adv Mater; 2018 Nov; 30(45):e1802233. PubMed ID: 30252965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4
    Zhang G; Campbell GR; Zhang Q; Maule E; Hanna J; Gao W; Zhang L; Spector SA
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.
    Cho MW; Lee MK; Carney MC; Berson JF; Doms RW; Martin MA
    J Virol; 1998 Mar; 72(3):2509-15. PubMed ID: 9499115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells.
    Levesque K; Zhao YS; Cohen EA
    J Biol Chem; 2003 Jul; 278(30):28346-53. PubMed ID: 12746459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
    Neffe AT; Meyer B
    Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
    [No Abstract]   [Full Text] [Related]  

  • 6. Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.
    Parrish NF; Wilen CB; Banks LB; Iyer SS; Pfaff JM; Salazar-Gonzalez JF; Salazar MG; Decker JM; Parrish EH; Berg A; Hopper J; Hora B; Kumar A; Mahlokozera T; Yuan S; Coleman C; Vermeulen M; Ding H; Ochsenbauer C; Tilton JC; Permar SR; Kappes JC; Betts MR; Busch MP; Gao F; Montefiori D; Haynes BF; Shaw GM; Hahn BH; Doms RW
    PLoS Pathog; 2012; 8(5):e1002686. PubMed ID: 22693444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion.
    Fantini J; Hammache D; Piéroni G; Yahi N
    Glycoconj J; 2000; 17(3 -4):199-204. PubMed ID: 11201791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
    LaBonte JA; Madani N; Sodroski J
    J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.
    Kato K; Sato H; Takebe Y
    J Virol; 1999 Jul; 73(7):5520-6. PubMed ID: 10364300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coreceptors: implications for HIV pathogenesis and therapy.
    Moore JP
    Science; 1997 Apr; 276(5309):51-2. PubMed ID: 9122710
    [No Abstract]   [Full Text] [Related]  

  • 12. CD4+ T cell-mimicking nanoparticles encapsulating DIABLO/SMAC mimetics broadly neutralize HIV-1 and selectively kill HIV-1-infected cells.
    Campbell GR; Zhuang J; Zhang G; Landa I; Kubiatowicz LJ; Dehaini D; Fang RH; Zhang L; Spector SA
    Theranostics; 2021; 11(18):9009-9021. PubMed ID: 34522224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
    Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.
    Dogo-Isonagie C; Lam S; Gustchina E; Acharya P; Yang Y; Shahzad-ul-Hussan S; Clore GM; Kwong PD; Bewley CA
    J Biol Chem; 2012 Apr; 287(18):15076-86. PubMed ID: 22403408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species-Specific Valid Ternary Interactions of HIV-1 Env-gp120, CD4, and CCR5 as Revealed by an Adaptive Single-Amino Acid Substitution at the V3 Loop Tip.
    Koma T; Yokoyama M; Kotani O; Doi N; Nakanishi N; Okubo H; Adachi S; Adachi A; Sato H; Nomaguchi M
    J Virol; 2021 Jun; 95(13):e0217720. PubMed ID: 33883222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.
    Hoorelbeke B; Xue J; LiWang PJ; Balzarini J
    PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
    Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
    Foda M; Harada S; Maeda Y
    Microbiol Immunol; 2001; 45(7):521-30. PubMed ID: 11529558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitic Acid Is a Novel CD4 Fusion Inhibitor That Blocks HIV Entry and Infection.
    Lee DY; Lin X; Paskaleva EE; Liu Y; Puttamadappa SS; Thornber C; Drake JR; Habulin M; Shekhtman A; Canki M
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1231-41. PubMed ID: 20001317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.